Prof Marshall is Head of the Centre for Children’s Cancer and Blood Disorders at the Sydney Children’s Hospital Network (SCHN) Randwick, and Head of Translational Research and Molecular Carcinogenesis at Children’s Cancer Institute Australia (CCIA). He has a longstanding clinical and translational research focus on relapse detection by minimal residual disease testing in leukaemia, and the therapy of high-risk or relapsed leukaemia.
His main preclinical research interests include investigating the mechanisms by which normal embryonal cells become cancerous, and improving the effectiveness of non-cytotoxic anti-cancer therapy in child cancer.